“General toxicity studies included chronic oral toxicity studies in rats and monkeys (treatment durations of up to 26 and 39 weeks, respectively).”
✓ VerifiedFDA multi-discipline review, p. 27Source ↗
Why that species
Kallikrein inhibition in rat and monkey plasma comparable to human
“monkey and rat plasma with mean EC50s of 5.4, 5.2, and 7.2 nM (Study BR-7353-005-REV-01), supporting the suitability of monkey and rat as the non-clinical species used for toxicology studies.”